Clincosm LogoSign in Get a demo

Urothelial Cancer

Showing 26 - 48 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Genotype-Phenotype Urothelial Cancer Registry

Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
Jun 2, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood

Completed
Has Results
  • Cervical Cancer
  • +4 more
  • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022

Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))

Terminated
Has Results
  • Urothelial Cancer
  • Bintrafusp alfa (M7824)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 25, 2022

Urothelial Cancer, Metastatic Solid Tumor Trial in New York (Colchicine)

Recruiting
  • Urothelial Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 5, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

Recruiting
  • Urothelial Cancer
  • Niraparib plus Cabozantinib
  • Barcelona, Cataluña, Spain
  • +10 more
Feb 8, 2022

Urothelial Cancer Trial in Italy (Pemigatinib)

Active, not recruiting
  • Urothelial Cancer
  • Bergamo, Italy
  • +4 more
Jan 25, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022

Urothelial Cancer Trial (pembrolizumab, paclitaxel, vinflunine)

Completed
Has Results
  • Urothelial Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 23, 2021

Urothelial Cancer Trial in Dallas (Stereotactic Ablative Radiation)

Terminated
  • Urothelial Cancer
  • Stereotactic Ablative Radiation
  • Dallas, Texas
    Aurelie Garant
Jun 10, 2021

Urothelial Cancer Trial in Worldwide (TKI258)

Completed
  • Urothelial Cancer
  • La Jolla, California
  • +25 more
Dec 11, 2020

Urothelial Cancer Trial in Australia, Canada (Nab-Paclitaxel, Paclitaxel)

Completed
Has Results
  • Urothelial Cancer
  • Douglas, Queensland, Australia
  • +36 more
Oct 28, 2020

Urothelial Cancer Trial in Philadelphia (PEMBROLIZUMAB, hypofractionated radiation)

Withdrawn
  • Urothelial Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 22, 2019

Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)

Completed
  • Urothelial Cancer
  • +2 more
  • Calgary, Alberta, Canada
  • +4 more
Aug 20, 2018

Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer

Completed
  • Urothelial Cancer
    • Chicago, Illinois
      University of Chicago
    May 1, 2018

    Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,

    Withdrawn
    • Non Small Cell Lung Cancer
    • +5 more
    • (no location specified)
    Dec 5, 2016

    Urothelial Cancer Trial in United States (Gemcitabine, Cisplatin, Sunitinib)

    Completed
    Has Results
    • Urothelial Cancer
    • Gemcitabine, Cisplatin, Sunitinib
    • Tucson, Arizona
    • +47 more
    Sep 15, 2016

    Urothelial Cancer Trial in Suresnes (Everolimus (Afinitor®))

    Completed
    • Urothelial Cancer
    • Everolimus (Afinitor®)
    • Suresnes, Ile de France, France
      Hôpital FOCH
    Jun 20, 2016

    Urothelial Cancer, Bladder Cancer Trial in Ann Arbor, Rochester, Portland (Neoadjuvant Cisplatin and Gemcitabine)

    Terminated
    Has Results
    • Urothelial Cancer
    • Bladder Cancer
    • Neoadjuvant Cisplatin and Gemcitabine
    • Ann Arbor, Michigan
    • +2 more
    Nov 4, 2015

    Urothelial Cancer, Bladder Cancer Trial in Ann Arbor (ABI-007 (Abraxane®))

    Terminated
    Has Results
    • Urothelial Cancer
    • Bladder Cancer
    • ABI-007 (Abraxane®)
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Aug 28, 2015

    Urothelial Cancer, Bladder Cancer Trial in Ann Arbor (Lapatinib and Paclitaxel)

    Withdrawn
    • Urothelial Cancer
    • Bladder Cancer
    • Lapatinib and Paclitaxel
    • Ann Arbor, Michigan
      University of Michigan
    Jan 15, 2013